Mounjaro sales up 125% in Q1. A new pill just launched. Q2 earnings could reset the story...
A new cloud business, a custom AI chip, and $145B in capex walk into an earnings report.
Every advanced GPU in every data center runs through TSMC's fabs. The Q2 number drops in four...
The GLP-1 diet revolution is creating a protein boom nobody on Wall Street saw coming.
480,000 deliveries, a Miami robotaxi launch, and a P/E above 350 all collide at Q2 earnings.
A federal compliance deadline just handed one domestic manufacturer a monopoly nobody is watching.
Three catalysts hit at once. Now the foundry story needs proof.
Azure grew 40% last quarter. The stock is trading like it didn't.
The biggest IPO in history is under pressure. August 6 is the date that matters.
Memory costs surging 271.79%, a $2,300–$2,500 foldable iPhone, and a CEO transition all converge in 20 days.